FDA cites Nephron again for ongoing issues the generics manufacturer has failed to resolve
Nephron Pharmaceuticals’ manufacturing facility in West Columbia, South Carolina, is still running afoul of the FDA. In its most recent Form 483 report, the agency has cited several problems that were evident